Is the subcutaneous allergen immunotherapy safe enough as a treatment modality?

EDİGER D., Yilmaz D., COŞKUN N. F., Gozu O.

ASTIM ALLERJI IMMUNOLOJI, vol.8, no.3, pp.150-156, 2010 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 3
  • Publication Date: 2010
  • Journal Name: ASTIM ALLERJI IMMUNOLOJI
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.150-156
  • Keywords: Asthma, allergic rhinitis, immunotherapy, adverse effects
  • Bursa Uludag University Affiliated: Yes

Abstract

Objective: Allergen immunotherapy has been proven to be effective and potentially curative therapy in allergic respiratory diseases and in venom allergy. But occurance of adverse systemic reactions due to specific allergen immunotherapy (SIT) remains still major problem. In this study we aimed to assess the adverse reactions of SIT which has been given to patients diagnosed as allergic asthma and/or rhinitis.